Status: Ongoing assessment
Aflibercept for wet age-related macular degeneration
Status: For external commissioning
Abiraterone for adult men with prostate cancer
Status: Ongoing assessment
CoronaVac COVID-19 Vaccine for Children 6 to 17 Years Old
Date of SOH Approval: 10 October 2022 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of CoronaVac COVID-19 Vaccine for children continue reading : CoronaVac COVID-19 Vaccine for Children 6 to 17 Years Old
Insulin Glargine and Insulin Detemir for Type 1 and Type 2 Diabetes Mellitus
On 10 October 2022, the OIC-Secretary of Health (SOH) approved the Health Technology Assessment Council (HTAC) recommendation for the government financing of both insulin glargine 10mL vial (100 IU/ml) and 3mL pre-filled pen (100 IU/ml) for patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) through their inclusion in the Philippine National Formulary (PNF). In continue reading : Insulin Glargine and Insulin Detemir for Type 1 and Type 2 Diabetes Mellitus